mucous membrane lesion
Recently Published Documents


TOTAL DOCUMENTS

2
(FIVE YEARS 1)

H-INDEX

0
(FIVE YEARS 0)

2021 ◽  
Vol 10 (33) ◽  
pp. 2854-2857
Author(s):  
Bhuvitha M. S. ◽  
Nandakumar G.

This is a rare case report of a thirty-eight-year-old male who presented with multiple asymptomatic hyper-pigmented papulonodular lesions on the face for the past two years without the association of pain or pruritus and with restriction of elbow movements. The diagnosis of multicentric reticulohistiocytosis was made on histopathological findings of Touton type of giant cells and sheets of foamy histiocytes along with immunohistochemistry (IHC) studies. Workup was done for other associated diseases. Multicentric reticulohistiocytosis (MRH) is also known as lipoid dermatitis,1 a rare disease which is characterised by the presence of extensive papulonodular cutaneous eruptions and severe, sometimes destructive arthropathy, followed by eruption of the skin and mucous membrane lesion.2,3 It’s a rare idiopathic nonLangerhans cell histiocytosis.4 This disorder is characterised by predominant cutaneous manifestation and joint involvements. The lesions may show regression and recurrence, many case studies show an association of this lesion with internal malignancies, autoimmune diseases, hyperlipidaemias, and tuberculosis.5,6 Few cases have shown musculoskeletal involvement with features such as myositis. The disease was described initially as reticulocytosis granuloma in 1952 by Caro and Senear, later the term was coined by Goltz and Laymon as multicentric reticulohistiocytosis in 1954.4 It is also known by different names such as giant cell histiocytosis, lipoid dermato-arthritis, lipoid-rheumatism and reticulohistiocytosis granuloma. The disease incidence is very low worldwide, less than 200 cases have been reported in literature5 and reports from India are limited.


2013 ◽  
Vol 2 (2) ◽  
pp. 25-29
Author(s):  
M Jamal Uddin ◽  
AZMI Maidul ◽  
MA Eakub ◽  
MA Wahab ◽  
L Khondker

A clinical trial was carried out in the Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka. The total number of patients was thirty and among them fifteen patients were treated with injection dexamethasone (Group-A) and other fifteen were treated with oral prednisolone (Group-B). The study showed that in Group-A, on admission and after 6 weeks, the mean number (±SD) of skin lesion of pemphigus was 36.87±8.40 and 5.27±1.624 respectively. In Group-B, on admission and after 6 weeks, the mean number (±SD) of skin lesion of pemphigus was 36.27±8.980 and 7.73±1.007 respectively. The study also observed that in group-A, on admission and after 6 weeks, the mean number (±SD) of mucous membrane lesion of pemphigus was 3.40±2.633 and 1.00±0.926 respectively. In Group-B, on admission and after 6 weeks, the mean number (±SD) of mucous membrane lesion of pemphigus was 3.33±2.225 and 1.87±1.246 respectively. Statistically significant improvement was observed in both groups in all clinical parameter after 6 weeks. Dexamethasone group showed statistically higher significant improvement than prednisolone group in all clinical parameter except Nikolsky’s sign. Injection dexamethasone appears to be more effective than oral prednisolone in early management of pemphigus vulgaris. DOI: http://dx.doi.org/10.3329/cbmj.v2i2.16694 Community Based Medical Journal 2013 July: Vol.02 No 02: 25-29


Sign in / Sign up

Export Citation Format

Share Document